scholarly journals Tobacco smoke exposure and sleep: estimating the association of urinary cotinine with sleep quality

2020 ◽  
Vol 40 (3) ◽  
pp. 70-80 ◽  
Author(s):  
Moe Zandy ◽  
Vicky Chang ◽  
Deepa P. Rao ◽  
Minh T. Do

Introduction A majority of studies on tobacco smoke exposure and sleep quality have relied on self-reported smoking, resulting in potential exposure misclassification and biases related to self-report. The objective of this study was to investigate associations between urinary cotinine, a biological marker of tobacco smoke exposure, and sleep quality measures, including sleep duration, sleep continuity or efficiency, sleep satisfaction and alertness during normal waking hours. Methods Using data on a national sample of 10 806 adults (aged 18–79 years) from the Canadian Health Measures Survey (2007–2013), we performed binary logistic regression analyses to estimate associations between urinary cotinine concentrations and sleep quality measures, while controlling for potential confounders. Additionally, we performed ordinal logistic regression to assess the association between urinary cotinine concentrations and increased number of sleep problems. Results Overall, 28.7% of adult Canadian survey respondents had urinary cotinine concentrations above the limit of detection (LOD), and the prevalence of each sleep problem ranged from 5.5% to 35.6%. Elevated urinary cotinine concentrations (quartile 4 vs. $lt;LOD) were associated with significantly higher odds of short or long sleep duration (OR = 1.41; 95% CI: 1.02–1.95; p-trend = .021), trouble falling or staying asleep (OR = 1.71; 95% CI: 1.28–2.27; p-trend = .003), sleep dissatisfaction (OR = 1.87; 95% CI: 1.21–2.89; p-trend = .011), and increased number of sleep problems (OR = 1.64; 95% CI: 1.19–2.26; p-trend = .001). Stronger associations were observed among females compared to males. Conclusion Using a biological marker of tobacco smoke exposure, our study contributes to the body of literature of toxic environmental exposures on sleep quality by supporting an association between tobacco smoke exposure and poorer sleep quality. To address the limitations of a cross-sectional study design and to better assess the temporality of tobacco smoke exposure and sleep quality, longitudinal studies are recommended.

2012 ◽  
Vol 13 ◽  
pp. S67-S68
Author(s):  
T.F. Leung ◽  
I.H.S. Chan ◽  
T.C. Liu ◽  
W.C. Chan ◽  
H.Y. Sy ◽  
...  

1984 ◽  
Vol 18 ◽  
pp. 229A-229A
Author(s):  
R Etzel ◽  
R Greenberg ◽  
N Haley ◽  
F Loda

Author(s):  
Jaclyn Parks ◽  
Kathleen E. McLean ◽  
Lawrence McCandless ◽  
Russell J. de Souza ◽  
Jeffrey R. Brook ◽  
...  

Abstract Background As smoking prevalence has decreased in Canada, particularly during pregnancy and around children, and technological improvements have lowered detection limits, the use of traditional tobacco smoke biomarkers in infant populations requires re-evaluation. Objective We evaluated concentrations of urinary nicotine biomarkers, cotinine and trans-3’-hydroxycotinine (3HC), and questionnaire responses. We used machine learning and prediction modeling to understand sources of tobacco smoke exposure for infants from the CHILD Cohort Study. Methods Multivariable linear regression models, chosen through a combination of conceptual and data-driven strategies including random forest regression, assessed the ability of questionnaires to predict variation in urinary cotinine and 3HC concentrations of 2017 3-month-old infants. Results Although only 2% of mothers reported smoking prior to and throughout their pregnancy, cotinine and 3HC were detected in 76 and 89% of the infants’ urine (n = 2017). Questionnaire-based models explained 31 and 41% of the variance in cotinine and 3HC levels, respectively. Observed concentrations suggest 0.25 and 0.50 ng/mL as cut-points in cotinine and 3HC to characterize SHS exposure. This cut-point suggests that 23.5% of infants had moderate or regular smoke exposure. Significance Though most people make efforts to reduce exposure to their infants, parents do not appear to consider the pervasiveness and persistence of secondhand and thirdhand smoke. More than half of the variation in urinary cotinine and 3HC in infants could not be predicted with modeling. The pervasiveness of thirdhand smoke, the potential for dermal and oral routes of nicotine exposure, along with changes in public perceptions of smoking exposure and risk warrant further exploration.


1992 ◽  
Vol 2 (2) ◽  
pp. 91-95
Author(s):  
Masahiro Kihara ◽  
Masako Kihara ◽  
Naoyuki Okamoto ◽  
Eigo Higashi ◽  
Shigeru Matsukura ◽  
...  

2011 ◽  
Vol 3 (9) ◽  
pp. 1995 ◽  
Author(s):  
Norihiro Kobayashi ◽  
Erika Banzono ◽  
Yuko Shimoda ◽  
Hiroyuki Oyama ◽  
Toshiomi Kunihiro ◽  
...  

2013 ◽  
Vol 9 (3) ◽  
pp. 447-456 ◽  
Author(s):  
Silvia Fustinoni ◽  
Laura Campo ◽  
Elisa Polledri ◽  
Rosa Mercadante ◽  
Laura Erspamer ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document